Several experimental observations appear to contradict clonal selection theories of humoral antibody formation (1). One of these is antigenic competition, a phenomenon whereby the immune response to one antigen can nonspecifically suppress the immune response of a non-cross-reacting antigen administered subsequently (2).
(From the Department of Microbiology and Immunology, Queen's University, Kingston, Ontario, Canada) (Received for publication 12 December 1970) Several experimental observations appear to contradict clonal selection theories of humoral antibody formation (1) . One of these is antigenic competition, a phenomenon whereby the immune response to one antigen can nonspecifically suppress the immune response of a non-cross-reacting antigen administered subsequently (2) .
Considerable controversy has arisen regarding the manner by which the response of one clone of cells which is capable of responding to one antigenic specificity, X, can affect the response of the second clone of cells which is capable of responding to a differing antigenic specificity, Y. Some investigators, on the basis of their experimental evidence, have suggested the existence of a hypothetical, multipotential lymphoid cell, occurring with a limited frequency (3, 4) , for which antigens actually compete. Such a cell would obviously not be allowed to exist within the theoretical framework of clonal-selecfion theories of immunity. Antithetically, if a mechanism of antigenic competition could be found which was compatible with clonal-selection theories, such a finding would greatly strengthen the apparent validity of the theories themselves. Other authors have interpreted their evidence as compatible with a role of soluble inhibitory factors released as a consequence of immunization, to account for the nonspecific depression of the immune response to other antigens (5) . This would imply that the term competition is a misnomer (5) .
A possible resolution of this problem came with the discovery that the immune response to many antigens requires the interaction of two separate functionally distinct cell types (6, 7) : the antigen reactive cell which is thymus-derived (T cell), 1 and the antibody-forming cell derived from the bone marrow (B cell). The question posed in the present work was whether the immunological deficiency associated with antigenic competition was a consequence of interference with the specific interactions of T and B cells for the second test antigenic specificity arising from immunological events induced by the initial suppressing antigen.
The results of the present work permitted us to put forth a new mechanism to account for antigenic competition based on deficiency of T and B cell interactions required for induction of humoral antibody formation to the second of the two antigens administered sequentially in a model of antigenic competition. The descriptive term antigen-induced suppression (AIS) was put forth to replace the term antigenic competition. A preliminary report of this work is being published3
Materials and Methods
Experimental Protoeol.--The materials and methods employed in the present work were similar to those reported in other studies (8) . 3 The individual experiments will be referred to in the text. In general, the various experiments carried out to delineate the characteristics of antigenic competition were reduplicated exactly, and evidence for altered cell-to-cell interaction in these experiments was sought indirectly employing theta (0) antigen assays and assessment of lymphoid organ mass, as will be shown below.
Anlmals.--Female C57BL/6J mice, 4 3-5 months of age, were used throughout these studies.
Lymphoid Cell Suspensions.---Cell suspensions used for these studies were prepared as previously described (8) . Assessment of spleen cell mass was determined by hemocytometer counts of the nucleated cell number in a fixed volume of suspensions prepared on pools of three to four individual spleens. In the text "spleen size" will refer to the cell count, not to spleen weight.
Theta Assays.--Anti-O antiserum was prepared according to the standard procedure of Reff and Allen (9) . The donor strain of thymus cells was CBA. Antiserum was tested for specificity by cytotoxic testing against thymus cells of either the AKR or CBA strain. In the latter case, no lysis was observed, in contrast with 100% cell lysis when CBA thymus cells were employed as target cells using suitably absorbed, fresh guinea pig complement (10) .
The assays for cytotoxicity were based on the method of Boyse et al. (11) , with the modification that for each dilution of antiserum (1:2 to 1:64) a normal AKR serum control was performed. The cytotoxicity with normal serum, which is generally in the range of 15-25%, was subtracted from the test values obtained with anti-0 serum at each antiserum dilution.
The results are recorded as percentage of cell lysis, which is a measure of the proportion of 0-positive cells in the spleen cell suspension. Most of the results illustrated in the figures were obtained using serum dilutions from 1:2 to 1:64. In some cases (Figs. 1 and 3 ) only the value obtained at the lowest (1:2) dilution was recorded for the various groups. Moreover, at this dilution, a strictly fiat plateau of eytotoxicity over a range of serial dilutions was not obtained in some instances, at which time a semiplateau was usually seen. In general, lysis at a dilution of 1:4 was usually 2-5% less than that observed at the 1:2 dilution, whereas at higher dilutions the drop was often much steeper from one dilution to the next.
The results recorded are based on experiments done in duplicate or triplicate. In turn, each experiment was performed using three mice per group. Hence, each point on any given figure represents the average value obtained from two or three separate experiments using a total of six to nine mice. 
RESULTS
Raft (12, 13) and Schlesinger (14) have independently devised a simple assay system to assess the relative numbers of T cells in any lymphoid population based on the fact that such cells carry the 0-antigen, while non-T cells do not. The assay was based on the discovery that the thymus cells of most strains of mice share a common 0-antigen (0-C3H) against which an isoantiserum may be prepared in the AKR strain which lacks this 0-C3H antigen (9) .
We have adopted this assay system to evaluate indirectly the T-B cell cooperative system, the implication being that striking deviations from normal values of the relative number of T cells in lymphoid tissues, such as the spleen of immune animals, could provide a useful index of the likelihood of cell cooperation involving T cells.
The question which was specifically posed at the outset of the present work was whether immunization with an initial antigen under various circumstances employed in studies of antigenic competition (8) ~ was associated with major alterations in the proportion of T cells in a given lymphoid cell population, in this case the spleen, and whether such deviations correlated in any way with known kinetic and dynamic features of antigenic competition.
Antigen-Induced Proliferative Changes in Spleens of Mice Immunized with Different Antigens.--In previous work, maximum immunosuppression induced
by immunization with the initial antigen occurred when the second test antigen was administered 24 days after immunization. The exact timing of maximum immunosuppression differed with the various pairs of antigens (8) .
In an initial experiment, the reduction in the proportion of 0-positive cells and the alteration in the lymphoid cell mass in the spleen were examined at daily intervals after immunization with keyhole limpet hemocyanin (KLH). The data is illustrated in Fig. 1 , from which it may be seen that the greatest reduction in 0-positivity occurred on the 2nd day after immunization with KLH coincident with the greatest increase in spleen cell size. A second preparation of KLH exhibited the greatest alteration in these parameters 3 days after immunization, and the material in both instances was maximally immunosuppressive when used as a suppressing antigen at 2 or 3 days respectively. These findings are essentially identical to the findings obtained with goose erythrocytes (GRBC), in which the greatest reduction in the proportion of 0-positive cells in association with the greatest increase in spleen cell size occurred 3 days after immunization 2, thus corresponding to the optimum time interval to achieve maximum immunosuppression in a model of antigenic competition.
The reduction in the proportion of T cells in association with increased spleen size was then examined at intervals of 2 or 3 days after immunization with a variety of antigens previously employed as suppressing antigens in models of antigenic competition. The results are summarized in Fig. 2 , from which it may be seen that all the antigens used generated a reduction in the proportion of T cells after immunization. Antigens administered in appropriate dosage, which are potent immunosuppressants in models of antigenic conipe- tition, were also associated with the greatest reduction in the proportion of T cells, and the largest increase in spleen cell size (see legends under figures for spleen counts); however, antigens such as polyvinylpyrrolidone (PVP), which are weakly suppressive of only a small number of antigens administered sub-sequently and in which the timing is critical to achieve suppression of the response to unrelated test antigens, produced a minimal reduction in the proportion of T cells and an increase in splenic mass (8) .
Effect of Antigen Dose on Capacity of Antigen to Cause Splenic Enlargement and a Reduction in the Proportion of O-Positive Cdls.--In previous studies of
antigenic competition employing the sequential administration of two noncross-reacting antigens, GRBC followed by rat erythrocytes (RRBC), the immunosuppression induced by the initial antigen was shown to increase to a 30- maximum at dose levels of 10-20%. Consequently, the effect of dose on the reduction of the proportion of T cells and the increase in spleen size was determined 3 days after immunization with varying doses of GRBC.
The results are shown in Fig. 3 . It may be seen that the reduction in the proportion of 0-positive cells 3 days after immunization with GRBC occurred maximally when a dose of 0.2 cc of 20% GRBC was administered. In addition, increasing the dose of GRBC resulted in progressively larger increases in spleen cell size until a maximum was reached at a 20% dose level. Increasing the dose to 50% GRBC actually resulted in less marked changes. Thus, the inverse relationships of increasing spleen cell size with decreasing proportion of 8-posi-tive cells correlated exactly with the dose levels of GRBC yielding maximum immunosuppression in a model of antigenic competition.
Effect of Primary vs. Secondary Immune Responses to an Antigen on the Capacity of that Antigen to Induce an Alteration in the Proportion of O-Positive
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Cells and Spleen Enlargement.--Previous studies in several laboratories have
indicated that a secondary immune response to an antigen is less effective than a primary immune response (using an equivalent dose) in suppressing the immune response to a sequentially administered non-cross-reacting antigen in a model of antigenic competition (15) (16) (17) .
It was decided therefore to assess the ability of a secondary immune response against a primary immune response to GRBC in altering the proportion of 0-positive cells and spleen cell numbers. Accordingly, a group of mice was injected with 0.2 cc of 10% GRBC on day 0 and again on day 30. 3 days later the spleens were removed, counted and assayed, and were compared to respective controls receiving only a single dose of GRBC 3 days before. As may be seen in Fig. 4 , the secondary immune response to GRBC was less effective in decreasing the proportion of 0-positive cells in the spleen 3 days after immunization. Moreover, the secondary response was equally less effective in generating splenic enlargement in comparison to a primary response induced by the administration of an equivalent dose of antigen.
Effect of Inhibiting the Immune Response to the Initial Antigen in Models of Antigenic Competition by Different Means on the Capacity of the Antigen to Induce O-Cell Population Changes and Spleen Enlargement.--Various workers,
including ourselves (18, 19) 3 , have manipulated the model of antigenic competition by employing various immunosuppressive agents coincident with, or soon after, administration of the initial suppressing antigen. The basic premise was that specific alteration of immune induction to the initial antigen, if it was associated with an abolition of immunosuppression in a model of antigenic competition, might provide some insight into the underlying mechanism of the phenomenon. During the course of such studies, it was shown by Wust and Hanna as well as ourselves (18) vented the suppressing capacity as well as the induction of immune response to the initial antigen. Cyclophosphamide was shown to behave similarly when administered a short time after administration of the initial suppressing antigen (19) . On the other hand, the observation that induction of tolerance to the initial antigen employing cyclophosphamide did not inhibit the capacity of antigen to suppress the immune response to subsequently administered non-cross-reacting antigen 3 was in essential agreement with other observations that induction of high dose tolerance is associated with continuing capacity to suppress employing models of antigenic competition (20, 21) .
In order to assess the correlation between these observations and the present proposed model to account for antigenic competition, several experimental protocols were reduplicated correlating immunosuppression in models of antigenic competition with a reduction in the proportion of 0-positive cells and a cell proliferation in the spleen leading to an increase in its size.
The data are illustrated in Figs. 5-7 and in Table I . effect of administering 0.60 #g of actinomycin-D/kg body weight 1 day after the initial antigen GRBC, corresponding to the time of 2 days before the administration of RRBC, on antigen-induced alteration of spleen size and 0-cell population changes. It can be seen that actinomycin-D both inhibited the ability of the antigen to cause an increase in spleen cell size and prevented the reduction in the proportion of 0-positive cells, both events occurring in association with the abolition of ilnmunosuppression by antigenic competition. A similar effect was observed with cyclophosphamide administered 1 day after GRBC injection (Fig. 6) . In contrast, however, when cyclophosphamide was used successfully to induce tolerance to the initial antigen (see Table I ), in this instance RRBC, continued proliferation subsequent to the administration of the tolerogen was observed such that the spleen increased in size and the proportion of 0-positive cells decreased in a fashion equivalent to Table I. immune animals (Fig. 7) . Thus, it appears that cell proliferation was persistent in such tolerant animals despite the virtual absence of any antibody production. Previous work had shown that RRBC injected into RRBC-tolerant animals retains its capacity to suppress the immune response to a subsequently administered unrelated antigen, in this case KLH, equivalent to the suppression observed in a control nontolerant group employing RRBC as the initial antigen?
In summary (see Table I ), close correlation was obtained between antigeninduced reductions in 0-positivity in the spleen with increased spleen size and The use of such model systems of antigenic competition has permitted many groups of workers to delineate the characteristics of this phenomenon (4, 5, 15, 22) . Both thymus-dependent and highly thymus-independent antigens are capable of acting as initial suppressing antigens, or as test antigens in models of antigenic competition, although thymus-independent antigens appear much less effective as test antigens (8) . 3 Immunosuppression varies with the dosage of both the initial and the test antigens. If the dose of the test antigen is kept constant the degree of immunosuppression will vary with the dose of the initial antigen, reaching a maximum with erythrocyte antigens when suspensions of 10-20% cells are administered (8) . Induction of a primary immune response to the initial antigen exerts a greater degree of immunosuppression of the test antigen than does induction of a secondary response with an equivalent dose of the initial antigen (15) (16) (17) . Actinomycin-D and cyclophosphamide administered in appropriate dosages after injection of the initial antigen prevent the capacity of that antigen to suppress the immune response to the test antigen administered subsequently (18, 19) ? On the other hand, induction of tolerance to the initial antigen employing cyclophosphamide, several weeks before the administration of the pair of antigens, does not diminish the capacity of the initial antigen to suppress the immune response to the test antigen} a finding similar to the "Liacopoulos phenomenon" (20, 21) .
The purpose of defining the characteristics of antigenic competition evolved from the desire of numerous groups of investigators to attempt to come to an understanding of the underlying lesion in antigenic competition. Thus, the phenomenon could be properly employed in experimental systems as a means of focusing on a specific aspect of induction of the immune response. To this end, there has evolved a considerable controversy as to whether the underlying mechanism is attributable to actual competition for a cell occurring with limited frequency (3, 4) , or the development of an inhibitory environment due to release of an inhibitory factor arising as a consequence of immunization to the initial antigen (5, 22) . Most workers would tend to agree that antigenic competition is not manifested by a competition for fixed macrophages or phagocytic cells (2, 8) , while competition for thymus and bone marrow-derived immunocompetent cells has not received popular acceptance since it would necessitate a requirement for a multipotent cell occurring with limited frequency. Current studies denoting specific cell receptors of an immunoglobulin character on lymphoid cells (23) (24) (25) (26) (27) would argue strongly for clonal selection and against the possibility of existence of a multipotent immunocompetent cell.
Recent findings that htmloral antibody formation to certain antigens depend upon a cell cooperation between thymus-and bone marrow-derived cells (6, 7) prompted us to investigate whether antigenic competition was associated with a specific environmental alteration which in some way diminished the efficiency of cell-to-cell interaction required to generate antibody formation to the test antigen. In this work, the number of cells carrying the ~-marker which are presumed to be T cells (12, 14) , as well as estimates of the total numbers of cells in maximally stimulated organs, were chosen initially as two indices representative of the alteration in lymphoid tissues occurring as a consequence of immunization to an antigen. It was considered that such studies would provide an indirect evaluation of the efficacy of cell cooperation occurring in immune environments to unrelated test antigens. For this purpose, mice were immunized with antigen in a dosage and form corresponding to the experimental protocols employed in previous studies of antigenic competition, and the effects of such immune induction were determined employing assays of the proportion of ~-containing cells and estimates of lymphoid cells in the spleens of immune animals.
Excellent correlation was obtained between the capacity of an initial antigen to suppress in a model of antigenic competition on the one hand, with the reduction in the proportion of T cells and increase in spleen cell mass on the other hand. Moreover, the reduction in the proportion of T cells was inversely related to the increase in splenic size. In this way, it was shown that the greatest reduction in the proportion of T cells in association with the greatest enlargement of spleen cell mass occurred 3 days after immunization, thus corresponding to the time at which the antigens, GRBC and KLH, were maximally immunosuppressive in antigenic competition. Numerous antigens caused a reduction in the proportion of T cells with a concomitant increase in splenic size. The greater the capacity of an antigen to suppress in a model of antigenic competition, the greater the reduction of the proportion of T cells with increase in spleen size was observed. For example, GRBC generated a much greater reduction in the proportion of T cells than did PVP, which is much less capable of suppressing the model of antigenic competition than the former antigen. The dose of antigen producing a maximal reduction in the proportion of T cells corresponded exactly to the dose of antigen maximally suppressive in antigenic competition. Secondary immune responses generated a lesser reduction in the proportion of T cells and an increase in spleen size than did primary immune responses, in direct agreement with the results of studies on antigenic competition. Actinomycin-D or cyclophospha.mide administered 24 hr after the initial antigen in a model of antigenic competition prevented suppression of the response to the test antigen, while similarly preventing the reduction in the proportion of T cells and the increased spleen size observed after immunization of untreated control animals. On the other hand, induction of cyclo-phosphamide-induced tolerance to the initial antigen did not prevent immunosuppression by antigenic competition, 3 nor did it alter the sharp reduction in the proportion of T cells and the increase in spleen cell size.
Several points are worthy of amplification. It is evident that the immune response to the initial antigen can be suppressed or inhibited altogether, without affecting the capacity of the antigen to retain its competitive ability, provided the antigen can still induce a proliferative response in the spleen generating splenic enlargement and a reduction in the proportion of T cells. Thus, if the immune response to the initial antigen is inhibited by cytotoxic drugs such as actinomycin-D or cyclophosphamide administered during the 3 day period employed in studies of antigenic competition, specific cell proliferation and increase in spleen size with overall reduction in the proportion of T cells is prevented. In these instances, antigenic competition does not occur. However, if the response to the initial antigen is nearly totally abolished by the induction of tolerance 3 wk previously employing cyclophosphamide, such that the immune response measured in terms of antibody formation is virtually absent, the splenic enlargement and cell proliferation generating a reduced proportion of T cells is not altered. Moreover, the tolerogen continues to be effective in suppressing a test antigen in antigenic competition.
In summary, it is evident that specific and massive cell proliferation appears to be a necessary prerequisite for the expression of antigenic competition, whereas antibody production per se is not. Dukor and Dietrich concluded from their recent findings that a "competitive proliferation" was responsible for the mechanism of antigenic competition (19) . However, there is no evidence that a competitive proliferation between clones of cells specific for one or two competing antigens has occurred. Indeed, if this were the case, one would expect suppression of both responses to occur when both antigens are administered simultaneously, instead of the normal responses which are actually observed (5) .
The apparent requirement of a proliferation-induced expansion in spleen cell number, the kinetics of which correlate with the kinetics of immunosuppression by antigenic competition, as well as with changes in 0-positivity in the spleens of immunized mice, provided evidence for the evolution of a model to explain the mechanism of antigenic competition, the essential features of which are shown in diagrammatic fashion in Fig. 8 . It is proposed that the injection of the initial antigen results in a massive proliferation of T and B cells of the specificity corresponding to that antigen, i.e., clonallv restricted cell proliferation. In this manner, specific T and B cells required for the interaction to antigen Y are "diluted out." The end result of this proliferation-dependent process is to decrease the chance of an interaction between T and B cells of identical specificity, required for the induction of an immune response to the test antigen (Y).
The greater the proliferative response to the first antigen, the greater the dilution effect, hence the more likely the response to the test antigen will be suppressed.
Since this theory, as proposed, is dependent upon a requirement for interacting T and B cells, it follows that suppression of immune respgnses to highly thymus-independent antigens such as PVP (28) s would be very difficult to suppress by antigenic competition, since such antigens do not appear to require the interaction of T with B cells (29) . We have previously reported this to be the case. 3 Thus, suppression of the anti-PVP response by a competing antigen is dependent upon a critical (high) dosage of the first antigen as well as a critical time interval, unlike models involving two competing heterologous erythrocytes. Alternatively, one could speculate that the suppression of the PVP response by unrelated antigens may be due to interference with interaction between antigen and B cells occurring in a hyperplastic spleen. Clearly, it should be more difficult to interfere with interactions requiring two components than with interactions requiring three components, namely those requiring contact of antigen with T and B cells, which is the minimal requirement for induction of antibody formation to T-dependent antigens.
In summary, this simple model presented herewith, to account for the mechanism of antigenic competition, consolidates as well as accounts for almost all of the characteristics of this phenomenon. In particular, it is compatible with current clonal selection theories of immunity (1) . In this regard, it is 5 Kerbel, R. S., and D. Eidinger. 1971 . Variable effects of anti-lymphocyte serum on humoral antibody formation; role of thymus dependency of antigen. J. Immunol. In press. ironic to note that the phenomenon of antigenic competition has for years been used as an argument against clonal-selection or cell-receptor theories of immunity (1) . Paradoxically, the model proposed is not only compatible with such theories, it is dependent upon them.
Finally, we should like to suggest that the term "antigenic competition" be replaced by a more descriptive phrase such as "antigen-induced suppression". The term has the quality of brevity and is conceptually correct, which is not true for the time-honored term antigenic competition.
SUMMARY
A striking correlation between the capacity of an antigen to nonspecifically suppress humoral immune responses of subsequently administered antigens which are non-cross-reacting, i.e. to manifest antigenic competition and produce enlargement of spleen size through cell proliferation, was found. Increase in spleen size was always accompanied by a drop in the normal proportion of thymus-derived cells to non-thymus-derived cells.
Various means of altering the immune response to the initial antigen, and hence, the capacity of that antigen to suppress in a model of antigenic competition were performed and correlated with changes in spleen size and in the proportion of 0-positive cells in the spleen. In all instances, when the experimental condition reduced or abolished antigenic competition, the increase in spleen size and reduction in the proportion of 0-positive cells in the spleen was reduced or abolished. Furthermore, under conditions in which the suppressive capacity of the initial antigen was unaltered, the increase in spleen size and reduction in 0-proportion occurred normally. Finally, the better the suppression in a model of antigenic competition, the greater the increase in spleen size and reduction in the proportion of 0-positive cells.
On the basis of these observations, it appears that there is a relationship between spleen enlargement through clonally restricted cell proliferation and the expression of antigenic competition; one cannot have the latter without the former. It is postulated that the immunological lesion associated with antigenic competition resides at the level of interference with cell interaction between thymus-derived antigen-reactive cells and marrow-derived antibodyforming cells. This occurs as a result of a relative "diluting out" of cells of both populations carrying antigenic specificity differing from the one(s) which induced the dilution effect in the first place. The net effect of this is to decrease the chance of a "hit" or interaction between a marrow-derived and thymusderived cell of the same specificities.
This mechanism, which is compatible with theories of clonal selection, and which in fact is dependent upon them, supports the view that the term "antigenic competition" is a misnomer; there is no competition by the antigens for anything. The term "antigen-induced suppression" is suggested as a more suitable alternative. 12:1271.) have suggested that the data initially interpreted in favor of the role of an inhibitory factor in antigenic competition (ref. 5 of bibliography), may necessitate reinterpretation based on the observations of requirement for T and B cell interaction in humoral antibody formation. We would concur with the implication that differences in cell cooperation could account for their data.
